Feed NXL
NX

Nexalin Technology, Inc. NXL · NASDAQ

$1.86 -8.37% (-$0.17)

Summary

23 / 100 · Bulios Score

What speaks for it

  • It has no debt and holds $1.00M in cash.

What to watch

  • Revenue fell by 39% a year over the last 3 years.
  • The company made a loss over the last 12 months.
  • The share price is above the Bulios Fair Price.
  • It missed profit estimates 6 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $1.86

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 4.4% a year over 5 years. Over the last 3 years it fell by 39% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $8.99M.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Device Sales brings in 45% of revenue. Equipment grew fastest, by 49% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy